Marex Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Marex Group’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Sell	3,873 -303	-7%	-$30.4K	﹤0.01%	730
2026 Q1	$386K	Buy	+4,176	New	+$393K	﹤0.01%	697

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's MIRM Position: Q2 2026 in Review

Marex Group reduced its Mirum Pharmaceuticals (MIRM) stake by 7.3% in Q2 2026, selling an estimated $30.4K and leaving 3,873 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Marex Group first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Marex Group held 3,873 shares of Mirum Pharmaceuticals worth $453K as of Q2 2026.
Marex Group sold 303 Mirum Pharmaceuticals shares in Q2 2026, an estimated $30.4K.
Mirum Pharmaceuticals made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #730 holding.
Marex Group first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.